The effect of aprotinin for hemostasis in open heart surgery

개심술시 Aprotinin의 지혈효과에 대한 고찰

  • Published : 1993.10.01

Abstract

The 26 patients were randomly selected among patients who underwent valve replacement from February 1992 through September 1993 at National Medical Center. They were divided into two groups, one control group[n=13], the other aprotinin group[n=13]. The aprotinin group recieved 15000 KIU/kg aprotinin in the CPB priming volume and 35000 KIU/kg aprotinin intravenously during operation. We checked preoperative and postoperative hemoglobin, platelet, prothrombin time, activated partial thromboplastin time, creatinine phosphokinase and lactic dehydrogenase. There was no difference in the patient`s above clinical parameters between both groups. The platelet count in both groups decreaced after operation. These findings demonstrated that the effectiveness of aprotinin was not associated with platelet number but probably associated with a protection of platelet function and a prevention of hyperfibrinolysis. The intraoperative and postoperative blood loss and requirement of blood were significantly reduced in aprotinin group.

Keywords

References

  1. Lancet v.1 Can Drugs Reduce Surgical Blood Loss?
  2. 개심 수술시 자가수혈(1판) 개심술시 aprotinin의 지혈효과 홍용우
  3. Ann Thorac Surg v.55 Effect of Low-Dose Aprotinin on Coagulation and fibrinolysis in Cadiopulmonary Bypass Kawasuji,M.;Ueyama,K.;Naoki,S.(et al.)
  4. N Engl J Med v.314 Treatment with desmopressin acetate to reduce blood loss after cardiac surgery:a double-blind randomized trial Salzman,E.W.;Weinstein,M.J.;Weintraub,R.M(et al.)
  5. Lancet v.2 Effect of Aprotinin on need for blood transfusion after repeat open heart surgery Royston,D.;Bidstrup,B.P.;Taylor,K.M.;Sapsford,R.N.
  6. J Thorac Cardiovasc Surg v.97 Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin(Trasylol) Bidstrup,D.;Royston,D.;Sapsford,R.N.;Taylor,K.M.
  7. Ann Thorac Surg v.51 Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass van Oeveren W.;Harder,M.P.;Rooxendaal,K.J.;Eijsman,L.;Wildevuur,C.R.H.
  8. J Thorac Cardiovasc Surg v.99 Aprotinin products platelets against the initial effect of cardiopulmonary bypass van Oeveren W.;Harder,M.P.;Roozendaal,K.J.;Eijsman,L.;Wildevuur,C.R.
  9. Lancet v.337 Lowdose aprotinin for reduction of blood loss after cardiopulmonary bypass Carrel,T.;Bauer,E.;Laske,A.;von Segesser,L.;Turina,M.
  10. Eur J Cardiothorac Surg v.5 Low dose aprotinin on blood saver in open heart surgery Covino,E.;Pepino,D.;Iorio,D.;Marino,L.;Ferrara,P.;Spampinato,N.
  11. Ann Thorac Surg v.44 Effect of aprotinin on hemostatic mechanisms during cardiopulmonary bypass van Oeveren W.;Jansen,N.J.G.;Bidstrup,B.P.(ed al.)
  12. J Thorac Cardiovasc Surg v.100 Increased anticoagulation during cardiopulmonaly bypass by aprotinin De Smet A.A.E.N.;Joen,M.C.N.;van Oeveren W.(et al.)
  13. J Thorac Cardiovasc Surg v.101 Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulpumonary bypass operation Havel,M.;Teufelsbauer,H.;Kn bel P.(et al.)
  14. J Thorac Cardiovasc Surg v.101 Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass Blauhut,B.;Gross,C.;Necek,S.;Doran,J.E.;Sp th P.;Lundsgaard-Hansen P.